Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01) | Apply Online

Opportunity Summary:

The National Cancer Institute (NCI) grant opportunity titled "Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01)" invites research projects that connect diet, immune function, and cancer prevention in a direct, biologically grounded way. The core goal is to build solid evidence for the real-world (physiological) importance of specific dietary components in changing how effectively NK cells can recognize and kill tumor cells. Rather than simply asking whether a nutrient or food compound has some immune effect in a lab dish, this announcement pushes applicants to demonstrate how dietary exposure influences NK cell tumoricidal activity in living systems and how that effect could plausibly contribute to preventing cancer.

A central emphasis of the FOA is defining practical exposure parameters. Applicants are expected to identify the minimum amount (dose) of a given dietary component and the minimum duration of intake needed to measurably modulate NK cell killing activity in a way that matters for cancer prevention. In other words, the research should move beyond broad claims like "compound X boosts immunity" and instead establish clear thresholds and timelines that could eventually inform prevention strategies, dietary guidance, or future intervention studies. Alongside these dose-and-time questions, the FOA also requires applicants to dig into the mechanisms that explain the observed change in NK cell function, linking dietary inputs to specific immune outputs.

To be considered responsive, proposed projects must include animal and/or human investigations. That requirement reflects the FOA's focus on physiological significance: the work needs to show that the dietary component produces meaningful effects in vivo, not just in vitro. Laboratory-based assays and cell culture experiments are allowed, but they are positioned as supporting tools rather than the main event. For example, applicants may use highly purified immune cell populations, defined tumor targets (including classic NK-sensitive tumor cells such as RMA-S that lack class I MHC expression), target-cell-free systems, or single-cell assays to pinpoint molecular pathways and confirm how NK cells are being altered. However, these in vitro approaches should be used to interpret and strengthen findings from animal models or human studies, not replace them.

Mechanistically, the FOA highlights several biological endpoints that are particularly relevant to NK cell-mediated tumor killing and that may serve as readouts for diet-driven modulation. These include changes at the interface between NK cells and cancer cells, such as tumoricidal activating or inhibitory receptors on NK cells and the corresponding ligands on tumor cells. The announcement also points to functional immune outputs like cytokine production, with interferon-gamma (IFN-g) given as a key example, since it is strongly tied to anti-tumor immune signaling. Another major area of interest is the cytotoxic machinery NK cells use to kill targets, especially the release of lytic granules and proteins such as granulysin, perforin, and serine proteases known as granzymes. Collectively, these targets reflect the FOA's interest in connecting dietary exposures to specific molecular and cellular events that plausibly translate into stronger tumor surveillance or elimination.

From an administrative and funding standpoint, this is an NIH R01 research project grant opportunity, meaning it is geared toward full-scale, hypothesis-driven research programs rather than early exploratory work. The FOA notes that it runs in parallel with a companion announcement of the same scientific scope that uses the R21 mechanism (PA-08-132), which is typically aimed at exploratory or pilot studies. This R01 version (PA-08-131) is therefore intended for more mature projects with strong preliminary rationale and a clear plan to deliver definitive in vivo evidence and mechanistic insight.

The opportunity was posted April 2, 2008, with an original and final closing date of May 7, 2011, and it was archived June 7, 2011. It falls under NIH and NCI programs associated with cancer cause and prevention research (CFDA 93.393) and cancer biology research (CFDA 93.396). There is no cost sharing or matching requirement. Eligibility is broad and includes state governments, public and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) entities), small businesses, for-profit organizations other than small businesses, and additional eligible applicants such as federal agencies, faith-based or community-based organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations) and regional organizations.

In practical terms, the FOA is seeking rigorous, prevention-oriented immunology and nutrition research that can answer three linked questions: which dietary components matter, what real-world dose and exposure window are required to change NK cell tumoricidal activity, and what biological mechanisms explain that change. It encourages mechanistic depth while keeping the project anchored in animal or human evidence, ensuring that any molecular findings are tied to outcomes relevant to cancer prevention rather than isolated cell-culture observations.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21)

Previous opportunity: Epidemiology Of Drug Abuse (R03)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 08 131

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 08 131) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 131", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.